PS Ratio
1.71
+0.05+3.01%
3 min ago
Summary:
Esperion Therapeutics price to sales ratio is currently 1.71, with a rise of +0.05 (+3.01%) during the most recent trading day. Over the past year, it has increased by +0.30 (+21.28%). ESPR PS ratio is now -99.42% below its all-time high of 292.68.ESPR PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR PS Ratio Performance
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +3.0% | +3.2% | +3.2% | +6.4% |
| 1 m1 month | +23.9% | +23.6% | +24.6% | - |
| 3 m3 months | +37.9% | +46.9% | +47.5% | - |
| 6 m6 months | -3.9% | +19.0% | +23.7% | - |
| ytdytd | -44.3% | -14.9% | +41.9% | - |
| 1 y1 year | +21.3% | +100.8% | +247.9% | +187.1% |
| 5 y5 years | -82.0% | -95.0% | -63.9% | +100.5% |
ESPR PS Ratio High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 1.71 | at high | 1.34 | +27.6% |
| 3 m | 3 months | 1.71 | at high | 1.07 | +59.8% |
| 6 m | 6 months | 2.45 | -30.2% | 1.07 | +59.8% |
| 1 y | 1 year | 4.61 | -62.9% | 1.07 | +59.8% |
| 3 y | 3 years | 8.78 | -80.5% | 0.82 | +108.5% |
| 5 y | 5 years | 292.68 | -99.4% | 0.82 | +108.5% |
| alltime | all time | 292.68 | -99.4% | 0.82 | +108.5% |
Esperion Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2024 | 1.71(-44.3%) |
| 2023 | 3.07(-51.2%) |
| 2022 | 6.29(+62.1%) |
| Date | Value |
|---|---|
| 2021 | 3.88(+31.1%) |
| 2020 | 2.96(-73.2%) |
| 2019 | 11.05 |
FAQ
- What is Esperion Therapeutics price to sales ratio?
- What is the all time high PS ratio for Esperion Therapeutics?
- What is ESPR price to sales ratio year-to-date change?
- What is Esperion Therapeutics PS ratio year-on-year change?
What is Esperion Therapeutics price to sales ratio?
The current PS ratio of ESPR is 1.71
What is the all time high PS ratio for Esperion Therapeutics?
Esperion Therapeutics all-time high price to sales ratio is 292.68
What is ESPR price to sales ratio year-to-date change?
Esperion Therapeutics price to sales ratio has changed by -1.36 (-44.30%) since the beginning of the year
What is Esperion Therapeutics PS ratio year-on-year change?
Over the past year, ESPR price to sales ratio has changed by +0.30 (+21.28%)